Your session is about to expire
← Back to Search
Online CBT Workshop for Postpartum Depression
N/A
Recruiting
Led By Ryan J Van Lieshout, MD, PhD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (t1), 1-month postpartum (t2), 2-months postpartum (t3), and 3-months postpartum (t4)
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if an online CBT-workshop helps reduce rates of PPD when added to usual treatment. (n=410)
Who is the study for?
This trial is for adults over 18 in Ontario, Canada, who are in their third trimester of pregnancy but not currently experiencing a major depressive episode. Participants should have risk factors for postpartum depression such as low income, past depression or anxiety, recent major stress, single status, history of abuse, or low social support.
What is being tested?
The study tests if an online one-day CBT-based workshop can reduce the rates of postpartum depression when added to usual treatment. It's a randomized controlled trial with half the participants receiving standard care and the other half also attending the workshop.
What are the potential side effects?
Since this intervention involves non-invasive therapy (CBT), side effects may be minimal compared to medical treatments. However, some individuals might experience emotional discomfort discussing sensitive topics during therapy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (t1), 1-month postpartum (t2), 2-months postpartum (t3), and 3-months postpartum (t4)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (t1), 1-month postpartum (t2), 2-months postpartum (t3), and 3-months postpartum (t4)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
EPDS score as a continuous outcome (Total EPDS) and an EPDS score of 13 or more at 2-months postpartum (T3) will serve as co-.
Secondary study objectives
Infant Temperament (Infant Behaviour Questionnaire-Revised (IBQ-R))
Maternal Anxiety (Generalized Anxiety Disorder 7-Item Scale (GAD-7))
Maternal Perceived Stress (Perceived Stress Scale (PSS))
+2 moreOther study objectives
Client Satisfaction (Client Satisfaction Questionnaire (CSQ-8))
Cognitive Behavioural Therapy Skills Acquisition
Cost Effectiveness - Quality-Adjusted Life Year
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Online 1-Day CBT-Based WorkshopExperimental Treatment1 Intervention
Participants assigned to the treatment arm will attend a day long CBT-based workshop delivered online by two trained facilitators in addition to receiving usual care.
Group II: Treatment as UsualActive Control1 Intervention
Participants assigned to the control arm will continue to receive standard prenatal care from their healthcare providers.
Find a Location
Who is running the clinical trial?
McMaster UniversityLead Sponsor
918 Previous Clinical Trials
2,615,885 Total Patients Enrolled
Ryan J Van Lieshout, MD, PhDPrincipal InvestigatorMcMaster University
2 Previous Clinical Trials
226 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with major depressive disorder before.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Online 1-Day CBT-Based Workshop
- Group 2: Treatment as Usual
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.